← FDA Drug Approvals (Drugs@FDA)

BIMATOPROST

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: EUGIA PHARMA · Approved 2022-10-06

Drug application

FDA Application #
ANDA205537
Application type
Abbreviated New Drug Application (Generic)
Brand name
BIMATOPROST
Generic name
BIMATOPROST
Active ingredients
BIMATOPROST
Dosage form
SOLUTION/DROPS
Route
OPHTHALMIC
Marketing status
Prescription
Sponsor
EUGIA PHARMA
Manufacturer
Aurobindo Pharma Limited
First approval
2022-10-06

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown